Table 3.
Outcome
|
Aspirin group (n = 30)
|
No aspirin group (n = 30)
|
P value
|
mRS score at 90 d, median (IQR) | 2 (1-3) | 3 (2-4) | 0.04 |
Bleeding complications, n (%) | 2 (6.7) | 2 (6.7) | 1.00 |
Intracranial hemorrhage, n (%) | 0 (0) | 0 (0) | - |
Gastrointestinal bleeding, n (%) | 0 (0) | 0 (0) | - |
Other major bleeding, n (%) | 2 (6.7) | 2 (6.7) | - |
Mortality rate, n (%) | 3 (10) | 4 (13.3) | 0.69 |
IQR: Interquartile range; mRS: Modified Rankin Scale.